Literature DB >> 29674389

Reduction in tuberculosis incidence in the UK from 2011 to 2015: a population-based study.

H Lucy Thomas1, Ross J Harris2, Morris C Muzyamba1, Jennifer A Davidson1, Maeve K Lalor1, Colin N J Campbell1,3, Sarah R Anderson1, Dominik Zenner1,3.   

Abstract

BACKGROUND: Following nearly two decades of increasing tuberculosis in the UK, TB incidence decreased by 32% from 2011 to 2015. Explaining this reduction is crucial to informing ongoing TB control efforts.
METHODS: We stratified TB cases notified in the UK and TB cases averted in the UK through pre-entry screening (PES) between 2011 and 2015 by country of birth and time since arrival. We used population estimates and migration data to establish denominators, and calculated incidence rate ratios (IRRs) between 2011 and 2015. We calculated the contribution of changing migrant population sizes, PES and changes in TB rates to the reduction in TB notifications.
RESULTS: TB IRRs fell in all non-EU migrant and UK-born populations between 2011 and 2015 (0.61; 95%  CI 0.59 to 0.64 and 0.78; 0.73 to 0.83 respectively), with the greatest decrease in recent non-EU migrants (0.54; 0.48 to 0.61). 61.9% of the reduction in TB notifications was attributable to decreases in TB rates, 33.4% to a fall in the number of recent/mid-term non-EU migrants and 11.4% to PES. A small increase in notifications in EU-born migrants offset the reduction by 6.6%.
CONCLUSIONS: Large decreases in TB rates in almost all populations accounted for the majority of the reduction in TB notifications, providing evidence of the impact of recent interventions to improve UK TB control. The particularly large decrease in TB rates in recent non-EU migrants provides evidence of the effectiveness of screening interventions that target this population. These findings will inform ongoing improvements to TB control. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  tuberculosis

Mesh:

Year:  2018        PMID: 29674389     DOI: 10.1136/thoraxjnl-2017-211074

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Million Migrants study of healthcare and mortality outcomes in non-EU migrants and refugees to England: Analysis protocol for a linked population-based cohort study of 1.5 million migrants.

Authors:  Rachel Burns; Neha Pathak; Ines Campos-Matos; Dominik Zenner; Srinivasa Vittal Katikireddi; Morris C Muzyamba; J Jaime Miranda; Ruth Gilbert; Harry Rutter; Lucy Jones; Elizabeth Williamson; Andrew C Hayward; Liam Smeeth; Ibrahim Abubakar; Harry Hemingway; Robert W Aldridge
Journal:  Wellcome Open Res       Date:  2019-01-17

2.  The NHS visitor and migrant cost recovery programme - a threat to health?

Authors:  J L Potter; M Burman; C D Tweed; D Vaghela; H Kunst; D Swinglehurst; C J Griffiths
Journal:  BMC Public Health       Date:  2020-04-20       Impact factor: 3.295

3.  Mycobacterium tuberculosis transmission in Birmingham, UK, 2009-19: An observational study.

Authors:  Timothy M Walker; Marc Choisy; Martin Dedicoat; Philip G Drennan; David Wyllie; Fan Yang-Turner; Derrick W Crook; Esther R Robinson; A Sarah Walker; E Grace Smith; Timothy E A Peto
Journal:  Lancet Reg Health Eur       Date:  2022-03-24

4.  Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.

Authors:  Sam Abbott; Hannah Christensen; Nicky J Welton; Ellen Brooks-Pollock
Journal:  Euro Surveill       Date:  2019-12

5.  Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.

Authors:  Luis C Berrocal-Almanza; Ross J Harris; Simon M Collin; Morris C Muzyamba; Olivia D Conroy; Adil Mirza; Anne-Marie O'Connell; Lynn Altass; Sarah R Anderson; H Lucy Thomas; Colin Campbell; Dominik Zenner; Nick Phin; Onn Min Kon; E Grace Smith; Ajit Lalvani
Journal:  Lancet Public Health       Date:  2022-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.